Christian Henry

Wave Life Sciences has appointed Christian Henry to its board of directors and as chair of its audit committee. Henry has held a variety of executive level positions at Illumina, including CFO, general manager of life sciences, general manager of genomic solutions, and most recently chief commercial officer. Prior to joining Illumina, he served as CFO of Tickets.com. He has also served as vice president of finance and corporate controller of Affymetrix, and has held various positions at Nektar Therapeutics, Sugen, and Ernst & Young.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.